The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


SINGULAIR 10mg film-coated tablets

10 milligram(s) Film-coated tablet

Imbat LimitedPPA1151/203/003

Main Information

Trade NameSINGULAIR 10mg film-coated tablets
Active SubstancesMontelukast
Strength10 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderImbat Limited
Licence NumberPPA1151/203/003

Group Information

ATC CodeR03DC Leukotriene receptor antagonists
R03DC03 montelukast

Status

Authorised/WithdrawnAuthorised
Licence Issued26/07/2013
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0023-002-003
Interchangeable List DocumentPDF of Interchangeable List
« Back